AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Heart Circ Physiol 278: H269-H276, 2000;
0363-6135/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Owaki, T.
Right arrow Articles by Klein, A. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owaki, T.
Right arrow Articles by Klein, A. S.
Vol. 278, Issue 1, H269-H276, January 2000

Endothelial cells potentiate phagocytic killing by macrophages via platelet-activating factor release

Tetsuhiro Owaki, Avedis Meneshian, Kosei Maemura, Sonshin Takao, Dajie Wang, Katherine C. Fuh, Gregory B. Bulkley, and Andrew S. Klein

Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland 21287-4685

The immunomodulatory function of endothelial cells (EC) includes the initiation of leukocyte margination, diapedesis, and activation through the upregulation of various cell surface-associated molecules. However, the effect that EC have on the phagocytic function of neighboring monocytes and macrophages is less well described. To address this issue, microvascular EC were cocultured with murine peritoneal macrophages, first in direct contact, then in a noncontact coculture system, and macrophage phagocytosis and phagocytic killing were assessed. The presence of increasing concentrations of EC resulted in a dose-dependent increase in macrophage phagocytic killing. This stimulatory effect was inhibited in a dose-dependent manner by the pretreatment of macrophage/EC cocultures with WEB-2086 or CV-6209, specific platelet-activating factor (PAF)-receptor antagonists, but not by anti-tumor necrosis factor-alpha , anti-interleukin (IL)-1alpha , or anti-IL-1beta . Furthermore, the effect was reproduced in the absence of EC by the exogenous administration of nanomolar concentrations of PAF. Microvascular EC potentiate macrophage phagocytic killing via the release of a soluble signal; PAF appears to be an important component of that signal.

phagocytosis; endothelium; immunomodulation; cytokines


This article has been cited by other articles:


Home page
 Infect. Immun.Home page
H. Beekhuizen and J. S. van de Gevel
Gamma Interferon Confers Resistance to Infection with Staphylococcus aureus in Human Vascular Endothelial Cells by Cooperative Proinflammatory and Enhanced Intrinsic Antibacterial Activities
Infect. Immun., December 1, 2007; 75(12): 5615 - 5626.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
M. Ogata, K. Nandate, T. Kawasaki, C. Kawasaki, M. Ozaki, and A. Shigematsu
A Platelet Activating Factor Receptor Antagonist Inhibits Cytokine Production in Human Whole Blood by Bacterial Toxins and Live Bacteria
Anesth. Analg., June 1, 2004; 98(6): 1767 - 1772.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
M. Takano, A. Meneshian, E. Sheikh, Y. Yamakawa, K. B. Wilkins, E. A. Hopkins, and G. B. Bulkley
Rapid upregulation of endothelial P-selectin expression via reactive oxygen species generation
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2054 - H2061.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online